Cite
HARVARD Citation
Frasco, M. et al. (2017). Incremental net monetary benefit of ocrelizumab relative to subcutaneous interferon β-1a. Journal of medical economics. pp. 1074-1082. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Frasco, M. et al. (2017). Incremental net monetary benefit of ocrelizumab relative to subcutaneous interferon β-1a. Journal of medical economics. pp. 1074-1082. [Online].